World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> US FDA Commissioner Promises Not To Bow To Political Pressure On COVID-19 Vaccine Timetable – President Donald Trump Says Any Delay Would Need White House Approval 23/09/2020 Grace Ren & Elaine Ruth Fletcher United States President Donald Trump told a press conference that any moves by the Food and Drug Administration (FDA) to delay emergency authorization of any forthcoming COVID-19 vaccine for an additional two months to ensure safety concerns are met, “sounds like a political move more than everything else” and such a delay “has to be […] Continue reading -> Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> WHO Issues Plea for US $35 Billion To Fast-Track COVID-19 Vaccines As United Nations General Assembly Convenes Virtually 15/09/2020 Elaine Ruth Fletcher As the 75th United Nations General Assembly opened in an unprecedented virtual session on 15 September, WHO issued a plea to the world’s leaders for funding to fight the COVID-19 pandemic – saying that US$ 35 billion is needed to fast-track development, procurement and distribution of 2 billion vaccine doses, treatments and tests over the […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> US FDA Commissioner Promises Not To Bow To Political Pressure On COVID-19 Vaccine Timetable – President Donald Trump Says Any Delay Would Need White House Approval 23/09/2020 Grace Ren & Elaine Ruth Fletcher United States President Donald Trump told a press conference that any moves by the Food and Drug Administration (FDA) to delay emergency authorization of any forthcoming COVID-19 vaccine for an additional two months to ensure safety concerns are met, “sounds like a political move more than everything else” and such a delay “has to be […] Continue reading -> Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> WHO Issues Plea for US $35 Billion To Fast-Track COVID-19 Vaccines As United Nations General Assembly Convenes Virtually 15/09/2020 Elaine Ruth Fletcher As the 75th United Nations General Assembly opened in an unprecedented virtual session on 15 September, WHO issued a plea to the world’s leaders for funding to fight the COVID-19 pandemic – saying that US$ 35 billion is needed to fast-track development, procurement and distribution of 2 billion vaccine doses, treatments and tests over the […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US FDA Commissioner Promises Not To Bow To Political Pressure On COVID-19 Vaccine Timetable – President Donald Trump Says Any Delay Would Need White House Approval 23/09/2020 Grace Ren & Elaine Ruth Fletcher United States President Donald Trump told a press conference that any moves by the Food and Drug Administration (FDA) to delay emergency authorization of any forthcoming COVID-19 vaccine for an additional two months to ensure safety concerns are met, “sounds like a political move more than everything else” and such a delay “has to be […] Continue reading -> Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> WHO Issues Plea for US $35 Billion To Fast-Track COVID-19 Vaccines As United Nations General Assembly Convenes Virtually 15/09/2020 Elaine Ruth Fletcher As the 75th United Nations General Assembly opened in an unprecedented virtual session on 15 September, WHO issued a plea to the world’s leaders for funding to fight the COVID-19 pandemic – saying that US$ 35 billion is needed to fast-track development, procurement and distribution of 2 billion vaccine doses, treatments and tests over the […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Health Leaders Plead For ‘Billions’ In Immediate Funding To Fight The Pandemic As G-20 Health & Finance Ministers Meet 17/09/2020 Elaine Ruth Fletcher Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> WHO Issues Plea for US $35 Billion To Fast-Track COVID-19 Vaccines As United Nations General Assembly Convenes Virtually 15/09/2020 Elaine Ruth Fletcher As the 75th United Nations General Assembly opened in an unprecedented virtual session on 15 September, WHO issued a plea to the world’s leaders for funding to fight the COVID-19 pandemic – saying that US$ 35 billion is needed to fast-track development, procurement and distribution of 2 billion vaccine doses, treatments and tests over the […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> WHO Issues Plea for US $35 Billion To Fast-Track COVID-19 Vaccines As United Nations General Assembly Convenes Virtually 15/09/2020 Elaine Ruth Fletcher As the 75th United Nations General Assembly opened in an unprecedented virtual session on 15 September, WHO issued a plea to the world’s leaders for funding to fight the COVID-19 pandemic – saying that US$ 35 billion is needed to fast-track development, procurement and distribution of 2 billion vaccine doses, treatments and tests over the […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Issues Plea for US $35 Billion To Fast-Track COVID-19 Vaccines As United Nations General Assembly Convenes Virtually 15/09/2020 Elaine Ruth Fletcher As the 75th United Nations General Assembly opened in an unprecedented virtual session on 15 September, WHO issued a plea to the world’s leaders for funding to fight the COVID-19 pandemic – saying that US$ 35 billion is needed to fast-track development, procurement and distribution of 2 billion vaccine doses, treatments and tests over the […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New COVID-19 Global Vaccine Facility Would Include Three-Track Finance Mechanism – But Finalizing Legal Structure Is Critical 31/08/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay The European Commission has announced that it will join the new WHO-sponsored COVID-19 vaccine facility (COVAX) with a € 400 million commitment – inching the visionary global fund much closer to reality. If the new COVAX facility becomes a reality, it would set a historic precedent of multilateral cooperation, not only on the pandemic, but […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> Posts navigation Older posts